Life Science Leader Magazine Supplements

CRO Guide 2016

The vision of Life Science Leader is to help facilitate connections and foster collaborations in pharma and med device development to get more life-saving and life-improving therapies to market in an efficient manner. Connect, Collaborate, Contribute

Issue link: https://lifescienceleadermag.epubxp.com/i/672523

Contents of this Issue

Navigation

Page 41 of 45

K E Y W W W.C R O L E A D E R S H I PA W A R D S .C O M 2016 CRO LEADERSHIP AWARDS WINNERS Company Profiles LIFESCIENCELEADER.COM THE CRO LEADERSHIP AWARDS 2016 40 CAPABILITIES COMPATIBILITY EXPERTISE QUALITY RELIABILITY CATEGORIES WON CATEGORIES WON CATEGORIES WON PRA Health Sciences Raleigh, NC www.prahs.com +1 919 786 8200 Roger Boutin BoutinRoger@prahs.com Key locations: Raleigh, NC, Blue Bell, PA, U.S.A.; Victoria, BC, Canada; Buenos Aires, Argentina; Johannesburg, South Africa; Zuidlaren/Assen/ Groningen, The Netherlands; Moscow, Russian Federation; Singapore DRUG LIFE CYCLE STAGES: Research & Development: Preclinical, Clinical (Phase 1, Phase 2, Phase 3) DRUG LIFE CYCLE STAGES: Research & Development: Preclinical, Clinical (Phase 1, Phase 2, Phase 3) Formulated Drug Production: Logistics DRUG LIFE CYCLE STAGES: Research & Development: Discovery, Preclinical, Clinical (Phase 1, Phase 2, Phase 3) MAIN SERVICE AREAS: Lab, Full Service Clinical MAIN SERVICE AREAS: Lab, Full Service Clinical MAIN SERVICE AREAS: Lab, Preclinical, Full Service Clinical "PPD's purpose and mission are to improve health by helping our customers deliver life-changing therapies. Our strategy of bending the cost and time curve of drug development gets therapies to patients faster and improves the productivity of our customers' R&D investments. As our customers' needs continue evolving, we remain committed to continuous improvement and innovation to address the diffcult challenges affecting the biopharmaceutical industry in our shared mission of delivering life-changing medicines to improve health." "PRA Health Sciences is delighted to once again receive these awards. This recognition is a tribute to our dedicated employees who continually seek new and innovative ways to transform clinical development and bring life-saving medicines to patients who need them." "I am absolutely thrilled that out of 65 candidate companies, QPS has again received a CRO Leadership Award—specifcally in the core categories of compatibility, expertise, quality, and reliability. Honestly, I am not surprised — I know how hard QPS employees have worked all year. They are passionate about their work and take pride in providing our customers with the most responsive, proactive, respectful, and high-quality service possible. I am proud of their accomplishment." THERAPEUTIC AREAS: neurodegenerative (Alzheimer's, Parkinson's, Huntington's, MS, ALS); CNS (depression, schizophrenia, ADHD); respiratory (asthma, COPD, allergy); metabolic (obesity, T2DM); inflammatory (RA, psoriasis); viral (HIV, HCV, HBV); oncology; & many more therapeutic indications DAVID SIMMONS Chairman & CEO COLIN SHANNON President & CEO BEN CHIEN Chairman, President & CEO QPS Holdings, LLC Newark, DE www.qps.com +1 512 350 2827 Lily Rosa lily.rosa@qps.com Key locations: Newark, DE; Springfeld, MO; Fargo, ND; Research Triangle Park, NC; Holly- wood, FL; South Miami, FL, USA; Groningen, The Netherlands; Graz, Austria; Hyderabad, India; Barcelona, Spain; and Taipei, Taiwan PPD Wilmington, NC www.ppdi.com +1 910 251 0081 PPD Business Development ppdinfo@ppdi.com Key locations: Operations in 46 countries, including in Wilmington, NC; Research Triangle, NC; Madison, WI; Austin, TX; Europe; China; Japan; Latin America. INDIVIDUAL ATTRIBUTE AWARDS: responsiveness INDIVIDUAL ATTRIBUTE AWARDS: data quality, offered innovative solutions, operational excellence, responsiveness, technology for real- time access to data INDIVIDUAL ATTRIBUTE AWARDS: data quality, operational excellence SERVICES & CAPABILITIES: Phase I, Phase II-IIIb, post-approval, bioanalytical, GMP, central & vac- cines & biologics labs, biomarker svcs. Consulting svcs: prod. dev., biosimilars, adaptive trial design, pediatrics, rare diseases, cardiovascular outcomes, medical devices THERAPEUTIC AREAS: cardiovascular, critical care, dermatology, dental pain research, endo- crine & metabolics, gastroenterology, hematology & oncology, immunology, infectious diseases, neuroscience, ophthalmology, respiratory, urology SERVICES & CAPABILITIES: Innovative full- service clinical & staffng solutions across all phases & therapeutic areas. Providing coverage across 80+ countries, we bolster our impressive global presence with local insights. THERAPEUTIC AREAS: neurology & psychiatry (CNS), oncology/hematology, infectious diseases, cardio-metabolic, rare diseases, vaccines, respira- tory, genitourinary, endocrinology, gastroenterol- ogy, immunology, hepatology, dermatology & biosimilar products

Articles in this issue

Links on this page

Archives of this issue

view archives of Life Science Leader Magazine Supplements - CRO Guide 2016